乳酸介导的组素乳酸化通过IL-33/ST2轴促进黑色素瘤血管生成
Mao Zhao1, Yuxuan Qian1, Lin He1
1Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Cell death & disease
|October 6, 2025
概括
乳酸盐和组织素的乳酸化通过增强IL-33/ST2通路来促进黑色素瘤血管生成. 与抗血管原药一起抑制乳酸或ST2提供了一种新的癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 代谢重编程 代谢重编程
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症的发病包括代谢重编程和血管生成.
- 乳酸盐是一种甘油性代谢物,通过基因素乳化通过表观遗传学调节基因.
- 乳酸和基因素乳化在瘤血管生成中的作用尚未完全理解.
研究的目的:
- 为了研究乳酸和基因素乳化在黑色素瘤血管生成中的作用.
- 阐明将乳酸盐,基因素乳酸和血管生成联系在一起的分子机制.
- 探索针对这种途径的潜在治疗策略.
主要方法:
- 利用黑色素瘤作为体外和体内研究的模型系统.
- 采用RNA测序和生物化学分析来识别分子标.
- 评估了联合治疗干预措施的协同效应.
主要成果:
- 发现乳酸盐和组织素的乳酸化促进了黑色素瘤血管生成.
- 乳酸盐通过基因素乳化增强内皮细胞中的ST2转录,增加对IL-33.3的反应.
- 乳酸抑制高内皮静脉的过渡,影响瘤的发展.
结论:
- 乳酸介导的基因素乳酸化通过IL-33/ST2轴促进黑色素瘤血管生成.
- 这项研究揭示了乳酸,基因素乳酸和癌症中的血管生成之间的新联系.
- 与抗血管原体药物联合抑制LDH/ST2为黑色素瘤提供了一个有前途的治疗方法.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


